Siriuspoint Ltd (SPNT) Stock Analysis
Verdict: BUY
Structural turnaround driven by high-margin service fees is masking a projected 32% EPS contraction in 2026, limiting near-term upside.
Investment score: 68/100
Analysis as of
Is Siriuspoint Ltd stock worth reviewing? The TradeMates thesis
SiriusPoint demonstrates strong operational recovery, but current pricing nears analyst targets ($25.00) while earnings are projected to normalize lower in 2026.
7-factor investment score
- Valuation: 60/100 (weight 20%)
- Financial Health: 70/100 (weight 15%)
- Technical Momentum: 75/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 65/100 (weight 10%)
- Risk-Adjusted Return: 72/100 (weight 15%)
Siriuspoint Ltd opportunities and risks
What speaks for SPNT
- Underwriting Turnaround
What speaks against SPNT
- Earnings Normalization Risk
Peers and competitors
- EG
- RNR
- CRE.L
- KG
- AOREF
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| SPNT | 5.4x | 0.8x | 3.6x | 45.5% | 15.5% | 12.0% |
| EG | 7.0x | 0.8x | 6.4x | 28.5% | 11.9% | 20.5% |
| RNR | 4.5x | 1.1x | 2.8x | 55.0% | 24.5% | 33.6% |
| KG | 2.2x | 2.1x | 3.6x | 67.6% | 96.2% | -98.3% |
| AOREF | 5.3x | 0.8x | 1.8x | 80.9% | 14.4% | 26.3% |
| Peer median | 4.9x | 1.0x | 3.2x | 61.3% | 19.4% | 23.4% |
Frequently asked questions about Siriuspoint Ltd (SPNT)
Is SPNT stock a good investment?
The TradeMates model rates Siriuspoint Ltd as BUY with an investment score of 68/100. SiriusPoint demonstrates strong operational recovery, but current pricing nears analyst targets ($25.00) while earnings are projected to normalize lower in 2026. This is algorithmic model output, not personal investment advice.
Is SPNT stock a buy?
The TradeMates model verdict for SPNT is BUY with an investment score of 68/100. Treat this as a model signal to review, not a personal buy recommendation.